NCT05547555

Brief Summary

This is a prospective randomised study of the evaluation of the clinical IVF results after invasive PGT-A embryo selection versus Non-invasive PGT-A assisted embryo selection in subfertile women.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 16, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 21, 2022

Completed
10 days until next milestone

Study Start

First participant enrolled

October 1, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
Last Updated

September 21, 2022

Status Verified

September 1, 2022

Enrollment Period

1.2 years

First QC Date

September 16, 2022

Last Update Submit

September 16, 2022

Conditions

Keywords

IVFPGT-ANON- INVASIVE PGT-ATIME LAPSEEMBRYO SELECTION

Outcome Measures

Primary Outcomes (3)

  • Embryotransfers to conceive

    The number of the embryotransfers required for women to conceive

    Up to the embryotransfer of the last enrolled patient (Dec 2023)

  • Time interval to conceive

    Time interval required for women to conceive (in months): from day of first embryotransfer to positive hCG test

    Up to the pregnancy test after the last embryo transfer of an enrolled patient (Jan 2024)

  • Cumulative Live Birth Rate

    Cumulative Live Birth Rate achieved after one OPU treatment

    Up to 38 weeks after the embryo transfer

Secondary Outcomes (2)

  • Abortion rate

    Up to 2nd trimester miscarriages

  • DaC rate

    during pregnancy according to Greek Law

Study Arms (2)

INVASIVE PGT-A

Women who proceed to embryo transfer after invasive PGT-A embryo selection.

Diagnostic Test: embryo selection

NON INVASIVE PGT-A

Women who proceed to embryo transfer after non- invasive PGT-A embryo selection.

Diagnostic Test: embryo selection

Interventions

embryo selectionDIAGNOSTIC_TEST

The basis of embryo selection for transfer: invasive PGT-A or after non-invasive PGT-A

INVASIVE PGT-ANON INVASIVE PGT-A

Eligibility Criteria

Age40 Years - 54 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women 40 years old or older who were divided in two groups according to the embryo selection criteria for embryotransfer: women in group A proceeded to embryo transfer after invasive PGT-A assisted embryo selection and women in group B proceeded to embryo transfer after non- invasive PGT-A assisted embryo selection.

You may qualify if:

  • Women who followed IVF treatment
  • years old or older
  • Single embryo transfer
  • blastocyst stage cultured embryos

You may not qualify if:

  • women under the age of 40 years
  • not blastocyst transfer (transfers performed at earlier embryo stage)
  • double embryotransfer
  • women who had embryotransfer according to morphological criteria women whose embryos were not time-lapse monitored

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assisting Nature

Thessaloniki, Thessaloniki, 57001, Greece

RECRUITING

MeSH Terms

Conditions

InfertilityAneuploidyChromosome Aberrations

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Evangelos Papanikolaou, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD, Fertility Specialist, Scientific Director at Assisting Nature IVF Clinic

Study Record Dates

First Submitted

September 16, 2022

First Posted

September 21, 2022

Study Start

October 1, 2022

Primary Completion

December 1, 2023

Study Completion

March 1, 2024

Last Updated

September 21, 2022

Record last verified: 2022-09

Locations